Post-fracture Risk Assessment: Target the Centrally Sited Fractures First! A Substudy of NoFRACT.


Journal

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
ISSN: 1523-4681
Titre abrégé: J Bone Miner Res
Pays: United States
ID NLM: 8610640

Informations de publication

Date de publication:
11 2019
Historique:
received: 03 05 2019
revised: 20 06 2019
accepted: 08 07 2019
pubmed: 17 7 2019
medline: 4 9 2020
entrez: 17 7 2019
Statut: ppublish

Résumé

The location of osteoporotic fragility fractures adds crucial information to post-fracture risk estimation. Triaging patients according to fracture site for secondary fracture prevention can therefore be of interest to prioritize patients considering the high imminent fracture risk. The objectives of this cross-sectional study were therefore to explore potential differences between central (vertebral, hip, proximal humerus, pelvis) and peripheral (forearm, ankle, other) fractures. This substudy of the Norwegian Capture the Fracture Initiative (NoFRACT) included 495 women and 119 men ≥50 years with fragility fractures. They had bone mineral density (BMD) of the femoral neck, total hip, and lumbar spine assessed using dual-energy X-ray absorptiometry (DXA), trabecular bone score (TBS) calculated, concomitantly vertebral fracture assessment (VFA) with semiquantitative grading of vertebral fractures (SQ1-SQ3), and a questionnaire concerning risk factors for fractures was answered. Patients with central fractures exhibited lower BMD of the femoral neck (765 versus 827 mg/cm

Identifiants

pubmed: 31310352
doi: 10.1002/jbmr.3827
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2036-2044

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 The Authors. Journal of Bone and Mineral Research published by American Society for Bone and Mineral Research.

Références

Oden A, McCloskey EV, Kanis JA, Harvey NC, Johansson H. Burden of high fracture probability worldwide: secular increases 2010-2040. Osteoporos Int. 2015;26(9):2243-8.
Nevitt MC, Cummings SR. Type of fall and risk of hip and wrist fractures: The study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 1993;41(11):1226-34.
Woolf AD, åkesson K. Osteoporosis. London: Clinical Publishing; 2008 p 160 (Atlas of Investigation and Management).
Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15(4):721-39.
Gehlbach S, Saag KG, Adachi JD, et al. Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res. 2012;27(3):645-53.
Johansson H, Siggeirsdottir K, Harvey NC, et al. Imminent risk of fracture after fracture. Osteoporos Int. 2017;28(3):775-80.
Roux C, Briot K. Imminent fracture risk. Osteoporos Int. 2017;28(6):1765-9.
Akesson K, Marsh D, Mitchell PJ, et al. Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013;24(8):2135-52.
Andreasen C, Solberg LB, Basso T, et al. Effect of a fracture liaison service on the rate of subsequent fracture among patients with a fragility fracture in the Norwegian capture the fracture initiative (NoFRACT): a trial protocol. JAMA Netw Open. 2018;1(8):e185701.
Borgen TT, Bjornerem A, Solberg LB, et al. High prevalence of vertebral fractures and low trabecular bone score in patients with fragility fractures: a cross-sectional sub-study of NoFRACT. Bone. 2019;122:14-21.
Kanis JA, Adachi JD, Cooper C, et al. Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF. Osteoporos Int. 2013;24(11):2763-4.
Kanis JA, McCloskey EV, Harvey NC, Johansson H, Leslie WD. Intervention thresholds and the diagnosis of osteoporosis. J Bone Miner Res. 2015;30(10):1747-53.
McCloskey EV, Oden A, Harvey NC, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. 2016;31(5):940-8.
Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-48.
Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14(5):821-8.
Schousboe JT, Vo T, Taylor BC, et al. Prediction of incident major osteoporotic and hip fractures by trabecular bone score (TBS) and prevalent radiographic vertebral fracture in older men. J Bone Miner Res. 2016;31(3):690-7.
Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res. 2003;18(11):1947-54.
Pothuaud L, Barthe N, Krieg MA, Mehsen N, Carceller P, Hans D. Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study. J Clin Densitom. 2009;12(2):170-6.
Hans D, Goertzen AL, Krieg MA, Leslie WD. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study. J Bone Miner Res. 2011;26(11):2762-9.
Nassar K, Paternotte S, Kolta S, Fechtenbaum J, Roux C, Briot K. Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range. Osteoporos Int. 2014;25(1):243-9.
Genant HK, Delmas PD, Chen P, et al. Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int. 2007;18(1):69-76.
Ahmed LA, Shigdel R, Joakimsen RM, et al. Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures. Osteoporos Int. 2015;26(8):2137-46.
Shigdel R, Osima M, Lukic M, et al. Determinants of transitional zone area and porosity of the proximal femur quantified in vivo in postmenopausal women. J Bone Miner Res. 2016;31(4):758-66.
Zebaze R, Atkinson EJ, Peng Y, et al. Increased cortical porosity and reduced trabecular density are not necessarily synonymous with bone loss and microstructural deterioration. JBMR Plus. 2018;3(4):e10078.
Bala Y, Zebaze R, Ghasem-Zadeh A, et al. Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Miner Res. 2014;29(6):1356-62.
Omsland TK, Emaus N, Tell GS, et al. Mortality following the first hip fracture in Norwegian women and men (1999-2008). A NOREPOS study. Bone. 2014;63:81-6.
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20(10):1633-50.
Fink HA, Ensrud KE, Nelson DB, et al. Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT). Osteoporos Int. 2003;14(1):69-76.
Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD. Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int. 2011;22(9):2439-48.
Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001;286(22):2815-22.
Siris ES, Brenneman SK, Barrett-Connor E, et al. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2006;17(4):565-74.
Delmas PD, Genant HK, Crans GG, et al. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone. 2003;33(4):522-32.

Auteurs

Tove T Borgen (TT)

Department of Rheumatology, Vestre Viken Hospital Trust, Drammen Hospital, Drammen, Norway.
Department of Clinical Medicine, University of Oslo, Oslo, Norway.

Åshild Bjørnerem (Å)

Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
Department of Obstetrics and Gynecology, University Hospital of North Norway, Tromsø, Norway.

Lene B Solberg (LB)

Division of Orthopedic Surgery, Oslo University Hospital, Oslo, Norway.

Camilla Andreasen (C)

Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
Department of Orthopedic Surgery, University Hospital of North Norway, Tromsø, Norway.

Cathrine Brunborg (C)

Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.

May-Britt Stenbro (MB)

Department of Rheumatology, Vestre Viken Hospital Trust, Drammen Hospital, Drammen, Norway.

Lars M Hübschle (LM)

Department of Orthopedic Surgery, Vestre Viken Hospital Trust, Drammen Hospital, Drammen, Norway.

Anne Froholdt (A)

Department of Physical Medicine, Vestre Viken Hospital Trust, Drammen Hospital, Drammen, Norway.

Wender Figved (W)

Department of Orthopedic Surgery, Vestre Viken Hospital Trust, Baerum Hospital, Baerum, Norway.

Ellen M Apalset (EM)

Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Jan-Erik Gjertsen (JE)

Department of Orthopedic Surgery, Haukeland University Hospital, Bergen, Norway.
Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Trude Basso (T)

Department of Orthopedic Surgery, St. Olavs University Hospital, Trondheim, Norway.

Ida Lund (I)

Division of Orthopedic Surgery, Oslo University Hospital, Oslo, Norway.

Ann K Hansen (AK)

Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
Department of Orthopedic Surgery, University Hospital of North Norway, Tromsø, Norway.

Jens-Meinhard Stutzer (JM)

Department of Orthopedic Surgery, Møre and Romsdal Hospital Trust, Molde Hospital, Molde, Norway.

Tone K Omsland (TK)

Department of Community Medicine and Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway.

Lars Nordsletten (L)

Department of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Orthopedic Surgery, Oslo University Hospital, Oslo, Norway.

Frede Frihagen (F)

Division of Orthopedic Surgery, Oslo University Hospital, Oslo, Norway.

Erik F Eriksen (EF)

Department of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH